Signaling pathways in cancer metabolism: mechanisms and therapeutic targets

Signal Transduct Target Ther. 2023 May 10;8(1):196. doi: 10.1038/s41392-023-01442-3.

Abstract

A wide spectrum of metabolites (mainly, the three major nutrients and their derivatives) can be sensed by specific sensors, then trigger a series of signal transduction pathways and affect the expression levels of genes in epigenetics, which is called metabolite sensing. Life body regulates metabolism, immunity, and inflammation by metabolite sensing, coordinating the pathophysiology of the host to achieve balance with the external environment. Metabolic reprogramming in cancers cause different phenotypic characteristics of cancer cell from normal cell, including cell proliferation, migration, invasion, angiogenesis, etc. Metabolic disorders in cancer cells further create a microenvironment including many kinds of oncometabolites that are conducive to the growth of cancer, thus forming a vicious circle. At the same time, exogenous metabolites can also affect the biological behavior of tumors. Here, we discuss the metabolite sensing mechanisms of the three major nutrients and their derivatives, as well as their abnormalities in the development of various cancers, and discuss the potential therapeutic targets based on metabolite-sensing signaling pathways to prevent the progression of cancer.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Energy Metabolism
  • Epigenesis, Genetic
  • Humans
  • Neoplasms* / drug therapy
  • Neoplasms* / therapy
  • Signal Transduction
  • Tumor Microenvironment